Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$12.14
-1.5%
$12.44
$11.68
$25.36
$561.17M1.12383,605 shs55,340 shs
Enovis Corporation stock logo
ENOV
Enovis
$34.75
+0.0%
$32.95
$28.83
$49.83
$1.98B1.7891,531 shs364,362 shs
NovoCure Limited stock logo
NVCR
NovoCure
$18.06
+3.2%
$17.65
$14.17
$34.13
$2.01B0.721.13 million shs228,660 shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$22.26
-0.3%
$20.21
$12.46
$28.68
$2.33B2.091.98 million shs419,652 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
+3.88%-1.37%-0.80%-6.27%-37.19%
Enovis Corporation stock logo
ENOV
Enovis
+5.18%+5.30%+9.28%+1.31%-21.70%
NovoCure Limited stock logo
NVCR
NovoCure
+3.67%-2.07%+3.00%+3.30%+9.44%
Warby Parker Inc. stock logo
WRBY
Warby Parker
+4.77%+2.83%+3.76%+34.90%+45.02%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
1.5238 of 5 stars
0.03.00.00.00.51.72.5
Enovis Corporation stock logo
ENOV
Enovis
3.4738 of 5 stars
3.43.00.00.02.81.71.9
NovoCure Limited stock logo
NVCR
NovoCure
3.5866 of 5 stars
3.41.00.04.51.91.70.0
Warby Parker Inc. stock logo
WRBY
Warby Parker
1.9708 of 5 stars
2.33.00.00.01.53.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.00
N/AN/AN/A
Enovis Corporation stock logo
ENOV
Enovis
2.80
Moderate Buy$55.6060.91% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.71
Moderate Buy$32.4382.22% Upside
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.61
Moderate Buy$22.884.40% Upside

Current Analyst Ratings Breakdown

Latest AVNS, ENOV, NVCR, and WRBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$48.00 ➝ $46.00
7/8/2025
NovoCure Limited stock logo
NVCR
NovoCure
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$30.00
6/27/2025
NovoCure Limited stock logo
NVCR
NovoCure
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$34.00
5/29/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00 ➝ $25.00
5/22/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$17.00 ➝ $22.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $24.00
5/14/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $70.00
(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$687.80M0.81$12.06 per share1.00$18.03 per share0.67
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.94$20.09 per share1.72$45.10 per share0.77
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M3.28N/AN/A$3.33 per share5.34
Warby Parker Inc. stock logo
WRBY
Warby Parker
$771.32M2.97$0.35 per share62.95$3.35 per share6.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$392.10M-$8.37N/A6.97N/A-55.80%6.26%4.63%7/30/2025 (Estimated)
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$13.95N/A10.83N/A-37.65%5.99%3.44%8/6/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.51N/AN/AN/A-26.41%-45.46%-13.34%7/24/2025 (Estimated)
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$20.39M-$0.12N/A219.10N/A-1.79%-2.48%-1.29%8/6/2025 (Estimated)

Latest AVNS, ENOV, NVCR, and WRBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74N/AN/AN/A$555.80 millionN/A
7/30/2025Q2 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.18N/AN/AN/A$165.50 millionN/A
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.40N/AN/AN/A$153.87 millionN/A
5/8/2025Q1 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.81+$0.07-$0.98$558.80 million$558.83 million
5/6/2025Q1 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.19$0.26+$0.07$0.14$161.75 million$167.50 million
4/24/2025Q1 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.47-$0.31+$0.16-$0.31$147.57 million$154.99 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.12
2.57
1.56
Enovis Corporation stock logo
ENOV
Enovis
0.52
2.55
1.32
NovoCure Limited stock logo
NVCR
NovoCure
0.27
1.47
1.41
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.70
2.30

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Enovis Corporation stock logo
ENOV
Enovis
98.45%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.64%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Warby Parker Inc. stock logo
WRBY
Warby Parker
18.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,22746.24 million45.02 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.12 million55.58 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.49 million105.33 millionOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
3,780104.50 million85.44 millionOptionable

Recent News About These Companies

Warby Parker Inc. (NYSE:WRBY) Receives $22.88 Average PT from Analysts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$12.14 -0.19 (-1.54%)
As of 12:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Enovis stock logo

Enovis NYSE:ENOV

$34.74 +0.01 (+0.01%)
As of 12:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$18.06 +0.55 (+3.16%)
As of 12:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Warby Parker stock logo

Warby Parker NYSE:WRBY

$22.26 -0.06 (-0.29%)
As of 12:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.